A 53-year-old Caucasian woman with long-standing, well controlled, severe rheumatoid arthritis, treated with methotrexate, salazopyrin, naprosyn, prednisone and plaquenil, presented with progressive visual loss in each eye. She had a past history of non-necrotizing anterior scleritis that was treated with increased doses of prednisone. She developed left then right central scotomas, reduced vision and optic atrophy. Eventually a diagnosis of methotrexate-induced optic atrophy was made.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1046/j.1442-9071.2002.00578.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intravitreal Methotrexate-Induced Regression of Proliferative Vitreoretinopathy.
Ophthalmol Retina
December 2023
Associated Retinal Consultants, Royal Oak, Michigan.
Good Gone Bad: Complications of Chemotherapy, Immunotherapy, and Radiotherapy on the CNS.
Curr Probl Diagn Radiol
December 2023
Mallinckrodt Institute of Radiology, St. Louis, MO.
Article Synopsis
- New cancer treatments, especially immunotherapy, are helping patients live longer and feel less sick, but there are still problems that can come from these therapies.
- Doctors who look at brain images, called neuroradiologists, can spot signs of these problems early on.
- The article explains various complications from different treatments, like chemotherapy and radiation, and stresses how important it is for doctors to recognize these issues to help patients stay safe and healthy.
2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity.
Clin Chim Acta
December 2018
Clinical Analysis Department, Hospital Universitari Son Espases, Research Institute of Health Sciences (IdISBa), Ctra. de Valldemossa, 79, 07120 Palma de Mallorca, Spain. Electronic address:
Background: High-dose methotrexate (HDMTX) therapy is a key component of many chemotherapy protocols. However, some patients develop HDMTX-induced nephrotoxicity. Carboxypeptidase-G2 (CPDG2) hydrolyses MTX into 2,4-diamino-N10-methylpteroic acid (DAMPA) and glutamic acid, and is used as a rescue agent in patients with nephrotoxicity and delayed elimination.
View Article and Find Full Text PDFApoptosis and electroretinogram after intravitreal injection of methotrexate in an experimental rabbit model.
Gen Physiol Biophys
April 2016
1. Research Institute of Ophthalmology, Giza, Egypt.
The aim of this study was to explore the changes in electroretinogram of rabbit retina and apoptosis in methotrexate-induced toxicity. Rabbits were divided into 5 groups. Group I served as control in which saline solutions was injected intravitreally.
View Article and Find Full Text PDFInvestigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal model.
Nutrients
September 2013
Mucositis Research Group, Centre for Personalised Cancer Medicine (CPCM), Centre for Clinical Research Excellence (CCRE) in Oral Health, Faculty of Health Sciences, University of Adelaide, Frome Road, Adelaide, SA 5005, Australia.
Chemotherapy-induced mucositis represents a significant burden to quality of life and healthcare costs, and may be improved through enhanced nutritional status. We first determined the safety of two nutritional drinks (plus placebo), and then potential gut protection in tumor-bearing rats in a model of methotrexate-induced mucositis. In study 1, animals were fed one of two test diets (or placebo or control chow pellets) for a total of 60 days and were monitored daily.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!